Susana Raimondi

Susana Raimondi

UNVERIFIED PROFILE

Are you Susana Raimondi?   Register this Author

Register author
Susana Raimondi

Susana Raimondi

Publications by authors named "Susana Raimondi"

Are you Susana Raimondi?   Register this Author

100Publications

3471Reads

32Profile Views

Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia.

Pediatr Hematol Oncol 2019 Oct 14;36(7):432-437. Epub 2019 Aug 14.

Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center , Beirut , Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08880018.2019.1648622DOI Listing
October 2019

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431.

Arch Pathol Lab Med 2019 Aug 20. Epub 2019 Aug 20.

From the Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Drs Mast, Mosse, Jones, and Head); the Division of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit (Dr Taub); the Department of Biostatistics, University of Southern California, Monrovia (Dr Alonzo and Mr Wang); the Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospital, Kansas City, Missouri (Dr Gamis); the Pathology and Laboratory Medicine Service, VA Tennessee Valley Healthcare System, Nashville (Dr Mosse); the Department of Pediatrics, University of New Mexico, Albuquerque (Dr Mathew); the Division of Hematology-Oncology, IWK Health Centre, Halifax, Nova Scotia, Canada (Dr Berman); the Departments of Oncology (Dr Campana and Ms Coustan-Smith) and Pathology (Dr Raimondi), St. Jude Children's Research Hospital, Memphis, Tennessee; the Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, The National University Cancer Institute, NUH Medical Centre, Singapore (Dr Campana and Ms Coustan-Smith); the Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis (Dr Hirsch); the Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada (Dr Hitzler); and the Division of Hematology/Oncology, The Hospital for Sick Children Developmental and Stem Cell Biology, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada (Dr Hitzler). Dr Mast now has a joint appointment at the Pathology and Laboratory Medicine Service, VA Tennessee Valley Healthcare System, Nashville. Dr Mathew is currently at the Department of Pediatrics, Presbyterian Health Services, Albuquerque, New Mexico. Dr Berman is currently at the Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada. Dr Jones is currently at Pathgroup Labs, Nashville, Tennessee. Dr Campana is no longer at the Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. Ms Coustan-Smith is no longer at the Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2018-0526-OADOI Listing
August 2019

POST: A framework for set-based association analysis in high-dimensional data.

Methods 2018 08 17;145:76-81. Epub 2018 May 17.

Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2018.05.011DOI Listing
August 2018

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.

J Clin Oncol 2017 Sep 2;35(26):3021-3029. Epub 2017 Aug 2.

Matthew A. Kutny, University of Alabama at Birmingham, Birmingham, AL; Todd A. Alonzo, University of Southern California; Cecilia H. Fu, Children's Hospital Los Angeles, Los Angeles; Robert B. Gerbing and Yi-Cheng Wang, Children's Oncology Group, Monrovia; James H. Feusner, Children's Hospital and Research Center Oakland, Oakland, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy A. Hirsch, University of Minnesota Medical Center-Fairview, Minneapolis, MN; Soheil Meshinchi, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO; and John J. Gregory Jr, Goryeb Children's Hospital, Morristown, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590801PMC
September 2017

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.

J Clin Oncol 2017 Aug 23;35(23):2674-2682. Epub 2017 Jun 23.

Jatinder K. Lamba, Lata Chauhan, and Miyoung Shin, University of Florida, Gainesville, FL; Michael R. Loken, Hematologics Inc; Rhonda E. Ries, Irwin D. Bernstein, and Soheil Meshinchi, Fred Hutchinson Cancer Research Center; Roland B. Walter and Soheil Meshinchi, University of Washington, Seattle, WA; Jessica A. Pollard, Maine Medical Center, Portland, ME; Jessica A. Pollard, Tufts University, Boston, MA; Yi-Cheng Wang, Children's Oncology Group, Monrovia; Todd A. Alonzo, University of Southern California, Los Angeles, CA; Richard Aplenc, Children's Hospital of Philadelphia, Philadelphia, PA; Betsy A. Hirsch, University of Minnesota, Minneapolis, MN; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; and Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549451PMC
August 2017

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.

J Clin Oncol 2016 Mar 19;34(7):747-55. Epub 2016 Jan 19.

Jessica A. Pollard, Maine Medical Center, Portland, ME; and Tufts University, Boston, MA; Michael Loken, Hematologics; Irwin D. Bernstein and Soheil Meshinchi, Fred Hutchinson Cancer Research Center; Irwin D. Bernstein and Soheil Meshinchi, University of Washington, Seattle, WA; Robert B. Gerbing and Todd A. Alonzo, Children's Oncology Group, Arcadia; Todd A. Alonzo, Keck School of Medicine of University of Southern California, Los Angeles, CA; Susana C. Raimondi, St Jude Children's Research Hospital, Memphis, TN; Betsy Hirsch, University of Minnesota Cancer Center, Minneapolis, MN; Richard Aplenc, Children's Hospital of Philadelphia, Philadelphia, PA; and Alan S. Gamis, Children's Mercy Hospitals and Clinics, Kansas City, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.6846DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872025PMC
March 2016

Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.

J Clin Oncol 2015 Dec 16;33(36):4247-58. Epub 2015 Nov 16.

Kim Klein, Gertjan Kaspers, Jacqueline Cloos, and Mathilda Bongers, Vrije Universiteit University Medical Center Amsterdam; Gertjan Kaspers and Ardine Reedijk, Dutch Childhood Oncology Group, The Hague; H. Berna Beverloo, Erasmus Medical Center, Rotterdam, the Netherlands; Christine J. Harrison, Newcastle University, Newcastle upon Tyne; Brenda Gibson, Royal Hospital for Sick Children, Glasgow, United Kingdom; Andrea Pession, Italian Association of Pediatric Hematology Oncology, Bologna, Italy; Dirk Reinhardt, Berlin-Frankfurt-Münster (BFM) -Germany, Essen; Martin Zimmerman and Ursula Creutzig, BFM-Germany, Hannover, Germany; Michael Dworzak, BFM-Austria, Vienna, Austria; Todd Alonzo, Donna Johnston, and Betsy Hirsch, Children's Oncology Group (COG) including Children's Cancer Group and Pediatric Oncology Group, Philadelphia (COG chair's office), PA; Michal Zapotocky, Czech Paediatric Hematology Working Group, Prague, Czech Republic; Barbara De Moerloose, European Organisation for Research and Treatment of Cancer-Children's Leukemia Group, Brussels, Belgium; Alcira Flynn, Grupo Argentino de Tratamiento de la Leucemia Aguda, Buenos Aires, Argentina; Vincent Lee, Hong Kong Paediatric Haematology and Oncology Study Group, Hong Kong, Special Administrative Region, People's Republic of China; Takashi Taga, Japanese Pediatric Leukemia/Lymphoma Study Group, Otsu; Akio Tawa, Japanese Pediatric Leukemia/Lymphoma Study Group, Osaka, Japan; Anne Auvrignon, French Leucémie Aiguë Myéloblastique Enfant Cooperative Group, Paris, France; Bernward Zeller, Nordic Society of Paediatric Haematology and Oncology, Oslo, Norway; Erik Forestier, Nordic Society of Paediatric Haematology and Oncology, Umeå, Sweden; Carmen Salgado, The National Program for Antineoplastic Drugs for Children, Santiago, Chile; Walentyna Balwierz, Polish Pediatric Leukemia Lymphoma Study Group, Krakow, Poland; Alexander Popa, Russian Acute Myeloid Leukemia Study Group, Moscow, Russia; and Jeffrey Rubnitz and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321085PMC
December 2015

Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Clin Cancer Res 2015 Jul 30;21(14):3187-95. Epub 2015 Mar 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington. Department of Epidemiology, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506237PMC
July 2015

Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma.

Int J Clin Exp Pathol 2014 15;7(1):451-5. Epub 2013 Dec 15.

Department of Pathology, Chi-Mei Medical Center Tainan, Taiwan ; Department of Pathology, Taipei Medical University Taipei, Taiwan ; Department of Pathology, National Taiwan University Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885505PMC
September 2014

SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.

Cancer Genet 2014 Sep 24;207(9):437-40. Epub 2014 Aug 24.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2014.08.002DOI Listing
September 2014

BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Pediatr Blood Cancer 2014 Apr 11;61(4):647-52. Epub 2013 Oct 11.

Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia; Children's Health Queensland Hospital and Health Service, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285339PMC
April 2014

The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.

Pediatr Blood Cancer 2014 Jan 16;61(1):81-8. Epub 2013 Aug 16.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington; Children's Oncology Group, Arcadia, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24700DOI Listing
January 2014

Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.

Am J Hematol 2013 Aug 20;88(8):694-702. Epub 2013 Jun 20.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington; Department of Epidemiology, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757130PMC
August 2013

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.

Pediatr Blood Cancer 2013 Jul 15;60(7):E38-41. Epub 2013 Feb 15.

Department of Oncology, St. Jude Children's Research Hospital, University of Tennessee College of Medicine, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.24483
Publisher Site
http://dx.doi.org/10.1002/pbc.24483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146405PMC
July 2013

A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma.

Genes Chromosomes Cancer 2011 Dec 24;50(12):1054-62. Epub 2011 Aug 24.

Department of Pathology, Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20923DOI Listing
December 2011

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

Mod Pathol 2011 Mar 12;24(3):430-42. Epub 2010 Nov 12.

Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.213DOI Listing
March 2011

Regression of a congenital mesoblastic nephroma.

Pediatr Blood Cancer 2010 Aug;55(2):364-8

Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049946PMC
August 2010